Outcome following coronary artery bypass grafting in patients with non-insulin diabetes mellitus 英文参考文献.docVIP

Available online /supplements/6/S2 Critical Care Volume 6 Supplement 2, 2002 19th Spring Meeting of the Association of Cardiothoracic Anaesthetists: selected abstracts Cambridge, UK, 21 June 2002 Association of Cardiothoracic Anaesthetists Published online: 9 July 2002 This article is online at /supplements/6/S2 ? 2002 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X) The publication of these abstracts was made possible by an unrestricted educational grant from Bayer plc 1 A survey of non-depolarising muscle relaxants used in cardiac anaesthesia and surgery S Briggs, R Thomas, P Goodyear, D Smith Department of Anaesthesia, Southampton University Hospitals NHS Trust, Tremona Road, Southampton SO16 6YD, UK Critical Care 2002, 6 (Suppl 2):1 Introduction: Residual neuromuscular blockade contributes to postoperative morbidity and mortality, and is more common with long-acting non-depolarising muscle relaxants (NDMRs) such as pancuronium [1]. This phenomenon may be a common occurrence in ‘fast-track’ managed cardiac patients administered long-acting NDMRs. We examine the usage of NDMRs in cardiac anaesthesia in the United Kingdom. comparison could be made) changed their choice of NDMR between NFT and FT patients. The majority of these anaesthetists (85.7%) remove pancuronium from their practice for FT patients. Of respondents, 20.7% (45/217) indicated that an assessment of neuromuscular function was part of an extubation protocol; 75.6% (34/45) of these respondents detailed only clinical methods, whilst 6.7% (3/45) indicated use of a ‘neuromuscular function monitor’ alone, with 15.6% (7/45) indicating use of both methods. Amongst the responses indicating ‘neuromuscular function monitor’ methods, an assessment of the ‘train-of-four’ was the commonest response. Less than 10% monitor the neuromuscular junction during surgery. Methods: A postal questionnaire was sent to 310 consultant cardiac